Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px
Document › Details

Correlogic Systems Inc.. (6/6/07). "Press Release: Correlogic Systems and JEOL Sign Research and Development Agreement. Joint Efforts to Advance Clinical Application of Mass Spectrometry". Rockville, MD.

Organisations Organisation Correlogic Systems Inc.
  Today Vermillion Inc. (Nasdaq: VRML)
  Group Vermillion (Group)
  Organisation 2 JEOL USA Inc.
  Group JEOL (Group)
Products Product mass spectrometry (MS)
  Product 2 NMR spectroscopy
Index term Index term Correlogic–Jeol: mass spectrometry, 200706– collab RnD to enhance performance following informal agreem on MS-assays
Person Person Levine, Peter J. (Correlogic 200211 CEO)
     


Correlogic Systems, Inc. and JEOL, Ltd. today announced the signing of a research and development agreement focused on further enhancing the performance of mass spectrometry in a clinical setting. JEOL, headquartered in Tokyo, is a leading global manufacturer of scientific instruments used for research and development in the fields of nanotechnology, life sciences, optical communication, forensics, and biotechnology. Correlogic, based in Rockville, Maryland has pioneered the use of pattern recognition technologies for the development of proteomic, metabolomic, and genomic based clinical prognostic and clinical diagnostic tests. Correlogic and JEOL have collaborated for more than a year under an informal agreement, and have made great strides in the continuing validation of various mass spectrometer-based assays. Details of the agreement were not released.

Over the past year, we have had a very close and productive research collaboration with JEOL", said Peter J. Levine, President and CEO of Correlogic Systems, Inc. "This agreement formalizes our link to one of the world's leading mass spectrometer and NMR manufacturers."

About Correlogic Systems, Inc.

Correlogic Systems, Inc. has developed patented technology and processes with a wide variety of applications for biomarker discovery, disease detection, and new drug discovery. The technology's first application has been in the field of proteomics - the study of human proteins. OvaCheck®, a blood test for the early detection of ovarian cancer, is Correlogic's first diagnostic test using its patented "Hidden Patterns" approach. The test is undergoing the final stages of its extensive validation process. Correlogic has entered into marketing agreements with Quest Diagnostics, Inc., and Laboratory Corporation of America for North America. Mitsui & Co., Ltd. and Quest Diagnostics are equity investors in Correlogic. Visit Correlogic at www.correlogic.com.

About JEOL, Ltd.

JEOL is a world leader in electron optical equipment and instrumentation for high-end scientific and industrial research and development. Core product groups include electron microscopes (SEMs and TEMs), instruments for the semiconductor industry (electron beam lithography and a series of defect review and inspection tools), and analytical instruments including mass spectrometers, NMRs and ESRs. Headquartered in Tokyo, Japan, the company has offices throughout the world.

Cautionary Statement: Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results could differ materially due to, among other things, operational and other difficulties associated with integrating acquired business, general business conditions, competition among managed care companies, rising health costs, trends in medical loss ratios, health care reform, delay in receipt of regulatory and other approvals for pending transactions and other regulatory issues.

   
Record changed: 2016-03-19

Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px

More documents for Vermillion (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px